.png){kind=logo}
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Dec 9, 2022Medtronic Canada is pleased to announce Health Canada has licensed the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days with Medtronic insulin...
Nov 15, 2022Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion setMedtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day...
Nov 1, 2022The MiniMed 780G system is the only insulin pump that automatically adjusts and corrects every five minutes to help keep sugar levels in rangeMedtronic Canada is pleased to announce that it has received a license from Health Canada for its MiniMed™ 780G system for people living with type 1 diabetes. This system with advanced hybrid...
Oct 18, 2022Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's...
Sep 1, 2022First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in Time in RangeMedtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced results from the Medtronic ADAPT study were published in The Lancet Diabetes & Endocrinology. The ADAPT study is...